Inari Medical, Inc. reaffirmed revenue guidance for the full year 2022. For the year, company reaffirming revenue guidance range of $360 million to $370 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.62 USD | -0.89% | +8.67% | -35.69% |
01/05 | Inari Medical Shares Jump on Higher Q1 Revenue | MT |
30/04 | Transcript : Inari Medical, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.69% | 2.44B | |
+73.39% | 12.38B | |
-17.34% | 7.99B | |
+17.07% | 7.21B | |
+3.34% | 5.79B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.17B | |
+3.59% | 2.03B | |
+4.85% | 1.88B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2022